Atlas Trials

Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Clinical trial NCT01700699 · UNKNOWN

Trial details

NCT number
NCT01700699
Sponsor
University of Salerno
Status
UNKNOWN
Study type
OBSERVATIONAL
Differentiated Thyroid Cancer
Start date
2012-10-01
Primary completion
2013-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.